ARWR - Company ID 0000879407
The table below shows ARROWHEAD PHARMACEUTICALS, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | $184.43M | $143.58M |
| Short-term investments | - | - | - | $0.00 | $126.73M | $85.02M |
| Receivables | $6.82M | - | $0.00 | $1.41M | $10.26M | $845.67K |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $950.64M |
| $695.47M |
| $419.52M |
| $405.30M |
| $384.60M |
| $322.37M |
| Property, plant & equipment | $382.51M | $386.03M | $290.26M | $110.30M | $48.67M | $30.88M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.39B | $1.14B | $765.55M | $691.94M | $710.15M | $522.50M |
| Accounts payable | $17.67M | $11.39M | $35.87M | $2.87M | $9.46M | $6.83M |
| Total current liabilities | $195.49M | $103.17M | $105.46M | $138.85M | $146.54M | $40.68M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$1.63B | -$1.63B | -$1.03B | -$820.75M | -$644.69M | -$503.84M |
| Total equity | $466.05M | $185.44M | $271.34M | $398.52M | - | $461.78M |